Optimi Health Completes MD-MA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
Insider Monkey·2026-02-09 15:03
Vancouver, British Columbia, February 9th, 2026, FinanceWireOptimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) (“Optimi” or the “Company”), a Health Canada-licensed manufacturer of pharmaceutical psychoactive medication products, today reported that it has completed its first export of MD-MA capsules to Australia in 2026 under the Authorised Prescriber Scheme.The export included 1,000 of Optimi’s MD-MA capsules in a standardised 60 mg dosage form, supplied for use in authorised clinical programs for th ...